Halozyme Reports Third Quarter 2018 Financial Results

Go back to Halozyme Reports Third Quarter 2018 Financial Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 69.62 +0.63 (0.91%)
Previous Close $68.99    52 Week High $18.39 
Open $69.38    52 Week Low $6.96 
Day High $70.21    P/E N/A 
Day Low $68.93    EPS $-0.58 
Volume 2,716,069